Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Integra Lifesciences (IART)

Integra Lifesciences (IART)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Integra Lifesciences 1100 CAMPUS ROAD PRINCETON NJ 08540 USA

P: 609-275-0500 F: 609-750-4277

Description:

Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.

Key Statistics

Overview:

Market Capitalization, $K 3,639,939
Enterprise Value, $K 4,063,249
Shares Outstanding, K 83,504
Annual Sales, $ 1,542 M
Annual Net Income, $ 169,080 K
Last Quarter Sales, $ 397,820 K
Last Quarter Net Income, $ 44,790 K
60-Month Beta 1.12
% of Insider Shareholders 4.20%
% of Institutional Shareholders 87.33%
Float, K 79,997
% Float 95.80%
Short Volume Ratio 0.50

Growth:

1-Year Return -39.73%
3-Year Return -26.53%
5-Year Return -13.65%
5-Year Revenue Growth 55.48%
5-Year Earnings Growth 80.68%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.82 on 07/27/22
Next Earnings Date 11/01/22
Earnings Per Share ttm 3.26
EPS Growth vs. Prev Qtr 10.81%
EPS Growth vs. Prev Year 3.80%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 01/04/17

IART Ratios

Ratio
Price/Earnings ttm 13.31
Price/Earnings forward 13.71
Price/Earnings to Growth 1.43
Return-on-Equity % 16.72%
Return-on-Assets % 7.36%
Profit Margin % 10.96
Net Margin % 6.29
Debt/Equity 0.93
Price/Sales 2.35
Price/Cash Flow 9.22
Price/Book 2.18
Book Value/Share 19.89
Interest Coverage 5.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar